Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$224.99 - $256.14 $10.2 Million - $11.6 Million
45,480 Added 298.9%
60,696 $14.6 Million
Q1 2023

May 12, 2023

SELL
$239.75 - $277.0 $5.56 Million - $6.42 Million
-23,177 Reduced 60.37%
15,216 $3.84 Million
Q4 2022

Feb 13, 2023

SELL
$241.42 - $282.29 $3.53 Million - $4.13 Million
-14,613 Reduced 27.57%
38,393 $10.2 Million
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $3.59 Million - $21.9 Million
14,540 Added 37.8%
53,006 $13.7 Million
Q2 2022

Aug 12, 2022

BUY
$237.11 - $299.66 $354,242 - $447,692
1,494 Added 4.04%
38,466 $9.75 Million
Q1 2022

May 13, 2022

SELL
$257.27 - $315.76 $5.63 Million - $6.91 Million
-21,875 Reduced 37.17%
36,972 $10.8 Million
Q4 2021

Feb 11, 2022

BUY
$292.08 - $329.01 $3.95 Million - $4.45 Million
13,523 Added 29.84%
58,847 $19.4 Million
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $2.86 Million - $3.49 Million
-10,500 Reduced 18.81%
45,324 $13.8 Million
Q2 2021

Aug 13, 2021

SELL
$225.08 - $271.69 $2.06 Million - $2.49 Million
-9,161 Reduced 14.1%
55,824 $15 Million
Q1 2021

May 14, 2021

BUY
$212.38 - $245.9 $3.67 Million - $4.25 Million
17,298 Added 36.27%
64,985 $14.6 Million
Q4 2020

Feb 12, 2021

SELL
$212.5 - $245.46 $3.68 Million - $4.25 Million
-17,321 Reduced 26.64%
47,687 $10.6 Million
Q3 2020

Nov 13, 2020

BUY
$177.16 - $215.33 $2.66 Million - $3.23 Million
15,008 Added 30.02%
65,008 $14 Million
Q2 2020

Aug 13, 2020

BUY
$128.7 - $176.83 $6.43 Million - $8.84 Million
50,000 New
50,000 $8.84 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.